Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 186.42 -59.39 (24.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $245.81 | 52 Week High | $0.52 | |||
| Open | $240.13 | 52 Week Low | $0.08 | |||
| Day High | $241.26 | P/E | N/A | |||
| Day Low | $183.50 | EPS | $-3.80 | |||
| Volume | 24,056,385 | |||||
